Alternative to the Lidocaine Drip Process
The associated coughing, choking, and gagging can cause patients to delay treatment or skip exams altogether, and the procedure is often aborted due to adverse complications. UltraEzAir solves the problem by nebulizing the Lidocaine and delivering it in a targeted mist with no discomfort.
Created to eliminate the persistent challenges associated with current methods of anesthetizing the oropharynx, larynx, and upper trachea, Airkor’s® UltraEzAir Ultrasonic Aerosolizer directs a narrow stream (2mm x 20 mm) of 4% nebulized topical lidocaine to targeted sites in the airway. Its targeted vapor does not trigger the common coughing, choking, and gagging associated with the current methods of airway numbing.
The UltraEzAir system is simple to use: It directly connects to the working side channel/biopsy port of all common flexible endoscopes with a onetime-use flexible line set and disposable nebulizing assembly.
By relieving the extreme discomfort associated with Lidocaine drips, UltraEzAir’s innovative airway numbing system provides laryngologists, ENTs, and speech language pathologists with a treatment option that better serves patients and helps to ensure they show up for the diagnostic and therapeutic procedures they need.